Sevoflurane Liquid
Product Images NDC 0781-6160

14 FDA label images from Sandoz Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 14 technical images submitted to the FDA as part of the official labeling for Sevoflurane (NDC 0781-6160). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sandoz Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure For Sevoflurane (Sevoflurane Usp Inhalation Anesthetic 1)

Chemical Structure For Sevoflurane (Sevoflurane Usp Inhalation Anesthetic 1)
Chemical structure of Sevoflurane showing carbon, hydrogen, fluorine atoms with trifluoromethyl (CF3) groups and a fluoromethoxy (OCH2F) group.*
FDA Label Image

Figure 8 (Sevoflurane Usp Inhalation Anesthetic 10)

Figure 8 (Sevoflurane Usp Inhalation Anesthetic 10)
A line graph comparing the effect of Sevoflurane combined with oxygen (Sevo/O2) and Sevoflurane combined with oxygen and nitrous oxide (Sevo/O2/N2O) on mmHg measurements across different MAC levels. The x-axis represents MAC level from baseline to 2.5, and the y-axis represents mmHg ranging from 40 to 100. Data points are shown with error bars.*
FDA Label Image

Figure 9 (Sevoflurane Usp Inhalation Anesthetic 11)

Figure 9 (Sevoflurane Usp Inhalation Anesthetic 11)
A line graph comparing measurements in dyne·sec·cm⁻⁵ at baseline and different MAC levels for two conditions: Sevoflurane with oxygen (Sevo/O₂) and Sevoflurane with oxygen and nitrous oxide (Sevo/O₂/N₂O). Data points are plotted with error bars, showing trends for both groups over MAC levels from baseline to approximately 2.0.*
FDA Label Image

Figure 10 (Sevoflurane Usp Inhalation Anesthetic 12)

Figure 10 (Sevoflurane Usp Inhalation Anesthetic 12)
A line graph comparing respiratory measurements in L/min/m² at different MAC levels (1.0, 1.5, 2.0) for Sevoflurane with O2 and Sevoflurane with O2/N2O. The y-axis ranges from 2 to 7 L/min/m², and baseline values are also shown. Data points include error bars.*
FDA Label Image

Container (Sevoflurane Usp Inhalation Anesthetic 13)

Container (Sevoflurane Usp Inhalation Anesthetic 13)
Label for Sevoflurane USP 250 mL, an inhalation anesthetic liquid. It includes storage instructions, dosage note referring to the package insert, and manufacturer details: Shanghai Hengrui Pharmaceutical Co., Ltd. for Sandoz Inc. The label displays the NDC 0781-6160-43 and features the Sandoz logo.*
FDA Label Image

Shipper Label (Sevoflurane Usp Inhalation Anesthetic 14)

Shipper Label (Sevoflurane Usp Inhalation Anesthetic 14)
Label for Sevoflurane Inhalation Anesthetic USP 250 mL liquid for respiratory inhalation. Manufactured by Shanghai Hengrui Pharmaceutical Co., Ltd., China, for Sandoz Inc., Princeton, NJ. Includes storage instructions with temperature range and a product NDC of 0781-6160-86. The label displays expiration date (JAN 2020), lot number, quantity, and multiple barcodes.*
FDA Label Image

Figure 1 (Sevoflurane Usp Inhalation Anesthetic 2)

Figure 1 (Sevoflurane Usp Inhalation Anesthetic 2)
A line graph depicting the concentration of Compound A in ppm as a function of the fresh gas flow rate in liters per minute. The graph shows a decreasing trend in Compound A concentration with increasing gas flow rate from 0.5 to 3 L/min, with a slight increase at 4 L/min.*
FDA Label Image

Figure 2 (Sevoflurane Usp Inhalation Anesthetic 3)

Figure 2 (Sevoflurane Usp Inhalation Anesthetic 3)
A line graph depicting the relationship between carbon dioxide flow (mL/min) on the x-axis and two variables on the y-axis: Compound A concentration (ppm) and maximum temperature (°C). The graph shows two trend lines, one for Compound A levels, which increase with carbon dioxide flow, and another for maximum temperature, which also rises as carbon dioxide flow increases.*
FDA Label Image

Figure 2a (Sevoflurane Usp Inhalation Anesthetic 4)

Figure 2a (Sevoflurane Usp Inhalation Anesthetic 4)
A scatter plot with a regression line illustrating the correlation between Sevoflurane (MAC-Hour) on the x-axis and Inspired Compound A AUC (ppm-hr) on the y-axis. The graph shows a strong positive correlation with r = 0.96 and a significance level of p < 0.001.*
FDA Label Image

Figure 3 (Sevoflurane Usp Inhalation Anesthetic 5)

Figure 3 (Sevoflurane Usp Inhalation Anesthetic 5)
A line graph comparing the uptake rates of Halothane, Isoflurane, Sevoflurane, Desflurane, and Nitrous Oxide (N2O) over 30 minutes of administration. The vertical axis represents the ratio of alveolar concentration to inspired concentration (FA/FI), while the horizontal axis shows minutes of administration. Different lines are identified with distinct markers for each anesthetic agent.*
FDA Label Image

Figure 4 (Sevoflurane Usp Inhalation Anesthetic 6)

Figure 4 (Sevoflurane Usp Inhalation Anesthetic 6)
A pharmacokinetic curve showing the elimination of five inhaled anesthetics over time. The y-axis represents the ratio of alveolar concentration at time t to initial alveolar concentration (FA/FA0) on a logarithmic scale, and the x-axis shows minutes of elimination from 0 to 120. The graph includes Halothane, Isoflurane, Sevoflurane, Desflurane, and N2O, each represented by distinct symbols.*
FDA Label Image

Figure 5 (Sevoflurane Usp Inhalation Anesthetic 7)

Figure 5 (Sevoflurane Usp Inhalation Anesthetic 7)
A line graph showing serum fluoride levels (μM) plotted against days post-anesthesia for five anesthetics: Methoxyflurane, Sevoflurane, Enflurane, Isoflurane, and Halothane. The data includes mean values with error bars for sample sizes ranging from 6 to 21 patients, depicting fluoride concentration changes over a 6-day period after anesthesia.*
FDA Label Image

Figure 6 (Sevoflurane Usp Inhalation Anesthetic 8)

Figure 6 (Sevoflurane Usp Inhalation Anesthetic 8)
A pharmacokinetic curve showing concentration (μM) versus time (hours) over 48 hours. The graph includes mean concentration and mean concentration plus one, two, and three standard deviations, illustrating the decline of the compound's concentration over time.*
FDA Label Image

Figure 7 (Sevoflurane Usp Inhalation Anesthetic 9)

Figure 7 (Sevoflurane Usp Inhalation Anesthetic 9)
A line graph comparing heart rate in beats per minute at various MAC levels for Sevoflurane with O2 and Sevoflurane with O2/N2O. The X-axis represents MAC levels, and the Y-axis shows beats per minute. Two data series are indicated with diamond and triangle markers, respectively, including baseline values.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.